CorMedix
CRMD
99 hedge funds and large institutions have $74.3M invested in CorMedix in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 9 closing their positions.
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
81% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 21
9% more funds holding
Funds holding: 91 → 99 (+8)
1% more capital invested
Capital invested by funds: $73.3M → $74.3M (+$1.06M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.21% less ownership
Funds ownership: 31.43% → 31.23% (-0.21%)
68% less call options, than puts
Call options by funds: $642K | Put options by funds: $2.02M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.21M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$822K |
| 3 |
State Street
Boston,
Massachusetts
|
+$537K |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$533K |
| 5 |
Jane Street
New York
|
+$516K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$7.77M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$398K |
| 3 |
Renaissance Technologies
New York
|
-$396K |
| 4 |
WCP
Wick Capital Partners
Wayne,
Pennsylvania
|
-$318K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$140K |
CRMD Hedge Fund Activity: Q2 2024 in Review
99 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q2 2024, worth a combined $74.3M — up 1.5% from $73.3M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new CRMD positions and 9 closed out — a net gain of 9 holders — while 38 added to existing stakes and 21 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.21M. The largest seller was Nomura Holdings, cutting an estimated $7.77M.
- 99 institutional investors held CorMedix (CRMD) as of Q2 2024, up from 91 in Q1 2024.
- Funds reported $74.3M of CorMedix stock for Q2 2024, up 1.5% quarter-over-quarter.
- 18 funds opened new CorMedix positions in Q2 2024 and 9 closed out, a net change of +9 holders.
- The largest CorMedix buyer in Q2 2024 was Millennium Management, an estimated $2.21M added.
- The largest CorMedix seller in Q2 2024 was Nomura Holdings, an estimated $7.77M sold.
Based on aggregated 13F filings for Q2 2024.